Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
about
Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma.Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma.Rituximab or irradiation promotes IL-17 secretion and thereby induces resistance to rituximab or irradiation.Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics.
P2860
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@ast
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@en
type
label
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@ast
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@en
prefLabel
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@ast
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@en
P2093
P2860
P1433
P1476
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma
@en
P2093
Chunyan Ji
Congcong Yin
Jingjing Ye
P2860
P304
P356
10.1371/JOURNAL.PONE.0148044
P407
P577
2016-01-26T00:00:00Z